These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
355 related articles for article (PubMed ID: 15888559)
1. Recurrence of membranoproliferative glomerulonephritis type II in renal allografts: The North American Pediatric Renal Transplant Cooperative Study experience. Braun MC; Stablein DM; Hamiwka LA; Bell L; Bartosh SM; Strife CF J Am Soc Nephrol; 2005 Jul; 16(7):2225-33. PubMed ID: 15888559 [TBL] [Abstract][Full Text] [Related]
2. Allograft failure in kidney transplant recipients with membranoproliferative glomerulonephritis. Angelo JR; Bell CS; Braun MC Am J Kidney Dis; 2011 Feb; 57(2):291-9. PubMed ID: 21215503 [TBL] [Abstract][Full Text] [Related]
3. Recurrence of renal disease after kidney transplantation in children: 24 years of experience in a single center. Müller T; Sikora P; Offner G; Hoyer PF; Brodehl J Clin Nephrol; 1998 Feb; 49(2):82-90. PubMed ID: 9524777 [TBL] [Abstract][Full Text] [Related]
4. Recurrent IgA nephropathy in renal transplant allografts. Wang AY; Lai FM; Yu AW; Lam PK; Chow KM; Choi PC; Lui SF; Li PK Am J Kidney Dis; 2001 Sep; 38(3):588-96. PubMed ID: 11532693 [TBL] [Abstract][Full Text] [Related]
5. Membranoproliferative glomerulonephritis recurrence after kidney transplantation: using the new classification. Alasfar S; Carter-Monroe N; Rosenberg AZ; Montgomery RA; Alachkar N BMC Nephrol; 2016 Jan; 17():7. PubMed ID: 26754737 [TBL] [Abstract][Full Text] [Related]
7. Differences between membranoproliferative glomerulonephritis types I and III in long-term response to an alternate-day prednisone regimen. Braun MC; West CD; Strife CF Am J Kidney Dis; 1999 Dec; 34(6):1022-32. PubMed ID: 10585311 [TBL] [Abstract][Full Text] [Related]
9. Recurrent type I membranoproliferative glomerulonephritis after renal transplantation and protective role of cyclosporine in acute crescentic transformation. Ahsan N; Manning EC; Dabbs DJ; Gifford RR; Yang HC Clin Transplant; 1997 Feb; 11(1):9-14. PubMed ID: 9067687 [TBL] [Abstract][Full Text] [Related]
11. Progression of renal allograft histology after renal transplantation in recurrent and nonrecurrent immunoglobulin A nephropathy. Jeong HJ; Park SK; Cho YM; Kim MS; Kim YS; Choi J; Kim SI; Lim BJ Hum Pathol; 2008 Oct; 39(10):1511-8. PubMed ID: 18620732 [TBL] [Abstract][Full Text] [Related]
12. Management of membranoproliferative glomerulonephritis type II with plasmapheresis. Kurtz KA; Schlueter AJ J Clin Apher; 2002; 17(3):135-7. PubMed ID: 12378549 [TBL] [Abstract][Full Text] [Related]
13. Long term outcome of renal allografts in patients with immunoglobulin A nephropathy. Ng YS; Vathsala A; Chew ST; Chiang GS; Woo KT Med J Malaysia; 2007 Jun; 62(2):109-13. PubMed ID: 18705440 [TBL] [Abstract][Full Text] [Related]
14. Recurrent or de novo IgA nephropathy with crescent formation after renal transplantation. Tang Z; Ji SM; Chen DR; Wen JQ; Chen JS; Liu ZH; Li LS Ren Fail; 2008; 30(6):611-6. PubMed ID: 18661411 [TBL] [Abstract][Full Text] [Related]
15. Recurrent nephrotic syndrome after living-related renal transplantation resistant to plasma exchange: report of two cases. Masutani K; Katafuchi R; Ikeda H; Yamamoto H; Motoyama K; Sugitani A; Kanai H; Kumagai H; Hirakata H; Tanaka M; Iida M Clin Transplant; 2005; 19 Suppl 14():59-64. PubMed ID: 15955171 [TBL] [Abstract][Full Text] [Related]